Among these, CHEK2 and PALB2, two of the genes involved in the homologous recombination pathway, have been associated with an increased risk of breast and other cancers, and are included in the NCCN guidelines for hereditary cancer risk assessment [12]. This evidence concerns the gene PALB2 and cancer.